Drotaverine Hydrochloride 80 mg + Mefenamic Acid 250 mg Film-Coated Tablet

Drotaverine Hydrochloride 80 mg + Mefenamic Acid 250 mg Film-Coated Tablet is a film-coated tablet formulated with Drotaverine Hydrochloride 80 mg + Mefenamic Acid 250 mg. The active ingredient profile is Drotaverine Hydrochloride; Mefenamic Acid, placing the product in the antispasmodic + nsaid combination category. The formulation combines an antispasmodic component with an analgesic or NSAID component for selected painful spasm-related conditions. The film coating provides a finished oral solid-dosage presentation and may support handling, stability and product acceptability. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.